Sanofi ADR (SNY)
$47.99 -$0.17 (-0.35%) 4:40 PM 12/11/24
NASDAQ | $USD | Drug Manufacturers - GeneralStock Data
-
Market Cap
$121.50B -
Day's Range
$47.75 - $48.12 -
Volume
2,234,831 -
52 Week Low / High
$45.22 - $58.97 -
PE Ratio
25.51x -
PEG Ratio
0.75 -
Dividend Frequency
annual
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 5
- Strong Buy
- 2
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $65.13
- Target Price
Company News
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? — Nov 15th, 2024
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department — Nov 15th, 2024
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
-
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat — Oct 25th, 2024
Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales. Continue reading View comments...
-
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? — Oct 31st, 2024
Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell? Continue reading View comments...
Portfolio
Comprised of 1 portfolios